ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

BHVN Biohaven Ltd

40.69
0.79 (1.98%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Biohaven Ltd BHVN NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
0.79 1.98% 40.69 19:00:00
Open Price Low Price High Price Close Price Previous Close
40.72 40.45 42.105 40.69 39.90
more quote information »

Recent News

Date Time Source Heading
4/22/202415:05PRNUSBiohaven Announces Closing of Public Offering and Full..
4/17/202415:05PRNUSBiohaven Announces Proposed Public Offering of Common Shares
4/13/202408:00PRNUSBiohaven Showcases Innovative Neuroscience Portfolio with 20..
2/29/202415:16EDGAR2Form 8-K - Current report
2/29/202415:05PRNUSBiohaven Reports Fourth Quarter and Full Year 2023 Financial..
1/08/202406:30EDGAR2Form 8-K - Current report
1/08/202406:30PRNUSBiohaven Highlights Progress Across Innovative Portfolio and..
1/02/202406:00PRNUSBiohaven to Present at the 42nd Annual J.P. Morgan..
12/01/202315:30PRNUSBiohaven Presents Expanded EEG and Safety Data for BHV-7000..
11/14/202315:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/14/202315:05PRNUSBiohaven Reports Third Quarter 2023 Financial Results and..
10/16/202306:00PRNUSBiohaven Presents Preclinical Data Demonstrating..
10/05/202315:05EDGAR2Form 8-K - Current report
10/05/202315:05PRNUSBiohaven Announces Closing of Public Offering and Full..
10/04/202315:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/02/202322:56PRNUSBiohaven Announces Pricing of $225 Million Public Offering..
10/02/202320:41EDGAR2Form 8-K - Current report
10/02/202316:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/02/202316:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/02/202315:36PRNUSBIOHAVEN ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON SHARES
10/02/202315:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
9/27/202305:58EDGAR2Form 8-K - Current report
9/14/202306:00PRNUSBiohaven Completes Enrollment in Pivotal Phase 3 Study of..
9/05/202306:00PRNUSBiohaven Announces Positive Data from its Exploratory..
7/31/202316:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/31/202315:29EDGAR2Form 8-K - Current report
7/31/202308:31PRNUSBiohaven's Taldefgrobep Alfa Receives EU Orphan Drug..
7/31/202305:59PRNUSBiohaven Reports Second Quarter 2023 Financial Results and..
7/28/202315:35EDGAR2Form 8-K - Current report
7/27/202307:42DJNBiohaven Told That FDA Won't Review NDA Application for..
7/27/202306:00PRNUSBiohaven Provides Preliminary EEG Data Update for Kv7..
5/31/202306:00PRNUSBiohaven Provides Overview of Clinical Progress, Regulatory..
5/25/202316:00PRNUSBiohaven to Present R&D Day at Yale School of Management
5/12/202315:30PRNUSBiohaven Reports First Quarter 2023 Financial Results and..

Your Recent History

Delayed Upgrade Clock